Robyn Fatooh, Director of New Product & Business Development, Immunology & Maternal Fetal Rare Diseases
Professional Overview
Robyn Fatooh is an accomplished pharmaceutical and medical device executive with over 20 years of diverse experience in the Johnson & Johnson organization. As the Director of New Product & Business Development for Immunology & Maternal Fetal Rare Diseases, she leverages her deep industry expertise and strategic acumen to drive innovative product development and commercial success in these critical therapeutic areas.
Experience Summary
Current Role
In her current role, Robyn is responsible for spearheading new product and business development initiatives within the Immunology and Maternal Fetal Rare Diseases portfolios at Johnson & Johnson. She collaborates cross-functionally to identify and evaluate potential product opportunities, manage the evaluation and selection process, and oversee the successful launch and commercialization of new products. Robyn's strategic leadership and strong business acumen have been instrumental in expanding the company's footprint in these specialized disease areas.
Career Progression
Robyn's career at Johnson & Johnson has been marked by progressive growth and increasing responsibilities. Prior to her current role, she served as the Group Product Director for Oncology & Metabolism in the Established Products division, where she drove successful lifecycle management strategies and optimized the commercial performance of the company's portfolio. She has also held positions in Worldwide Strategy & Insights, Leadership Excellence, and Regional Business Management, demonstrating her versatility and ability to contribute across various functions and therapeutic areas.
Academic Background
Robyn holds a Bachelor's degree in Psychology from the University of California, Los Angeles (UCLA), where she graduated with honors. Her academic background provides a solid foundation for her understanding of patient behavior and the psychological factors that influence healthcare decision-making.
Areas of Expertise
- New product and business development
- Product lifecycle management
- Therapeutic area strategy and commercialization
- Cross-functional collaboration and stakeholder management
- Data-driven decision making and analytics
- Leadership and team development
Professional Impact
Robyn's contributions have had a meaningful impact on Johnson & Johnson's success in the Immunology and Maternal Fetal Rare Diseases space. She has played a key role in the successful launch and commercialization of several groundbreaking products, driving significant revenue growth and improving patient outcomes. Robyn's strategic vision, innovative thinking, and commitment to excellence have earned her a reputation as a respected leader within the organization.
Conclusion
With her extensive industry experience, strong business acumen, and proven track record of success, Robyn Fatooh is poised to continue driving transformative change in the Immunology and Maternal Fetal Rare Diseases domains at Johnson & Johnson. Her dedication to patient-centric innovation and her ability to navigate complex challenges make her a valuable asset to the organization.
